News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

Health care is Montana’s largest industry and is projected to experience more job growth than any other industry in the state over the next eight years. However, with the State employment rate hovering around 2.6%, health care facilities are facing extreme workforce shortages. Because of this high demand for health care workers, Bitterroot Health and Bitterroot College are partnering to address these workforce issues through innovation and collaboration.

Montana State University has joined with a dozen other universities in the region to form a partnership aimed at creating economic development opportunities around emerging high-tech industries.

Montana State University
|
December 17, 2022

INDUSTRY Bozeman, a multi-tenant modern office space, has broken ground on an 87,000-square-foot building to be located on the Montana State University Innovation Campus.

Montana’s Tonix Pharmaceuticals, a clinical-stage biopharmaceutical company, announced that it has entered into a sponsored research agreement with Boston Children’s Hospital to study TNX-15001 (Fc-modified anti-CD40L mAb) for the prevention of graft-versus-host disease (GvHD) after hematopoietic stem cell transplantation (HCT) in animals.

The University of Montana recently secured $5.1 million in federal grants from the Health Resource and Service Administration, leading to the formation of a new UM Office of Health Research & Partnership. The office will use the HRSA funding for programs to bolster the health care workforce and increase access to quality health care in rural and underserved parts of Montana.

ARTICLES OF INTEREST

When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but her husband urged her to take the test anyway.

National Institutes of Health
|
March 26, 2024

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.

BIO.News
|
January 30, 2024

As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.

NIH National Institute on Aging
|
January 18, 2024

Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR

National Institutes of Health SEED
|
January 18, 2024

Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.

NEWSLETTER

Newsletter
|
May 7, 2024

View the Spring 2024 Newsletter Newsletter now!

Newsletter
|
February 20, 2024

View the Winter II 2024 Newsletter now!